CDS Information : AO090005000436

Display	1000bp 10000bp 100000bp Clone

Aspergillus oryzae RIB40 (= NBRC 100959) chromosome1	Legend Jump
Contig Overview  Genome Proteome  Clone

Center position	SC009SC005SC30847Q_0141te14	change
ID		change
Gene name		change

Organism	Aspergillus oryzae RIB40 (= NBRC 100959)
Replicon	chromosome1
Contig	SC005
Start / Stop / Direction	1,136,361 / 1,137,877 / +
Location	join(1136361..1136439, 1136512..1136735, 1136801..1137877)
Type	CDS
Length	1,380 bp (459 aa)
Intron	1136440..1136511, 1136736..1136800

Product	dihydrolipoamide acetyltransferase
Gene name
Functional category	Metabolism - [C] Energy production and conversion
EC number
Note
KEGG pathway
Sequence feature
References

Proteome results	2D-PAGE YPD_liquid (1) 2D-PAGE YPD_filter (2) 1D-PAGE-LC YPD_liquid 1D-PAGE-LC YPD_filter MDLC YPD_filter Show sequence

BLASTP Database:UniProtKB:2010_04 show BLAST table	1 E=0 Q2USG5_ASPOR Dihydrolipoamide acetyltransferase Alignment 2 E=0 B8MX81_ASPFN Pyruvate dehydrogenase complex, dihydrolipoamide acetyltransferase Alignment 3 E=0 A1DCR1_NEOFI Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase Alignment 4 E=0 Q4WGP1_ASPFU Pyruvate dehydrogenase complex, dihydrolipoamide acetyltransferase component, putative Alignment 5 E=0 B0YB22_ASPFC Pyruvate dehydrogenase complex, dihydrolipoamide acetyltransferase Alignment
HAMAP	No significant hit
InterPro	No significant hit
SignalP	No significant hit
TMHMM	No significant hit
SOSUI	No significant hit

size of protein	459 amino acids
molecular mass	48,723.32 Da
pI	5.06
aa composition	Ala Val Leu Ile Phe Trp Pro Met Gly Ser 12.2 (56aa) 8.3 (38aa) 7.6 (35aa) 5 (23aa) 2.8 (13aa) 0.9 (4aa) 7.2 (33aa) 1.5 (7aa) 7.4 (34aa) 7.4 (34aa) Thr Cys Asn Gln Tyr Lys His Arg Asp Glu 6.1 (28aa) 0.2 (1aa) 3.3 (15aa) 4.1 (19aa) 1.3 (6aa) 7.8 (36aa) 1.1 (5aa) 2.8 (13aa) 4.6 (21aa) 8.3 (38aa)

>AO090005000436 dihydrolipoamide acetyltransferase
ATGGCTGACGTTGCTATCCCTATTTTCAGACCCCAATTGCCCGCCTTCGCTGCCCTTTCC
CGCTACTATGCCTCCAAGTCCTTCCCCCCTCACACTATCATTAGCATGCCTGCTTTGTCG
CCAACAATGCTTGCTGGAAACATCGGTGCCTGGCAGAAGAAGCCCGGCGATTCCCTGCAG
CCCGGAGATGTTTTGGTCGAGATTGAGACCGATAAGGCACAGATGGATTTCGAGTTCCAA
GAAGAAGGTGTCTTGGCTAAAGTTCTGAAGGAAACTGGTGAGAAGGAGGTTGCTGTCGGC
TCCCCTATCGCCGTCCTCGTTGAAGAGGGCACTGATGTTTCGTCGTTCGAGTCGTTCACC
GCTGAGGATGCCGGTGGTGACAAGGGTGCTGCCCCAGCTCAGGAGAGCAAGGAAGAATCC
AAGGGTGCTGCTGATGCTGCTCCCGCTTCTACACCGGCTCCCGAGCCTGCTGCTCAGGAG
CCCGAGACCTCGGGTGAGAAGCTTCAGCCCAGTCTCGACCGTGAGCCTACTATCAGCCCT
GCTGCCAAGGCTCTTGCTCTGGAGAAGGGTGTGCCAATCAAGGCCCTTAAGGGCACTGGC
CGAGGCGGTCAGATCACCAAGGAGGATGTTGAGAAGTACAAGCCCAGCGCTTCTGCCGCT
GCTGGCCCTACCTATGAGGATATCCCTCTTACATCCATGCGCAAGACTATTGCCAGCCGC
CTTCAGCAATCCACCAGAGAGAACCCCCACTTCTTCGTCTCAACTACTCTGTCTGTCACT
AAGCTTCTGAAGCTCCGCCAGGCCCTTAACGCCTCTGCCGATGGCAAGTACAAGCTTTCC
GTCAATGACTTCCTTGTCAAGGCTTGTGCTGCGGCTCTTCAGAAGGTGCCGGCTGTCAAC
TCCAGCTGGCACGAGGAGAACGGCCAGGTAGTCATCCGCCAGCACAAGAATGCCGACATC
AGTGTTGCCGTTGCCACTCCTGCTGGACTGATCACCCCTGTTGTGAAGAACGTCCAGGGT
CTCGGCCTCTCCAGCATCTCTAACTCTATCAAGGACCTTGGTAAGCGTGCTCGCGACAAC
AAGCTTAAGCCGGAGGAGTACCAGGGTGGTACTTTCACCATCAGCAACATGGGAATGAAC
CCTGCCGTTGAGCGGTTCACTGCTGTTATCAACCCCCCTCAGGCTGGTATCCTGGCTGTT
GGCACCACCCGCAAGGTTGCCGTCCCTGTTGAGACTGAGAACGGTACCGAGGTTGAGTGG
GACGACCAGATCATTGTGACTGGCAGCTTTGACCACAAGGTTGTCGATGGTGCCGTTGGT
GCTGAATGGATTAAGGAGCTGAAGAAGGTTGTTGAGAACCCCTTGGAGCTGCTGCTCTAA


>AO090005000436 dihydrolipoamide acetyltransferase
MADVAIPIFRPQLPAFAALSRYYASKSFPPHTIISMPALSPTMLAGNIGAWQKKPGDSLQ
PGDVLVEIETDKAQMDFEFQEEGVLAKVLKETGEKEVAVGSPIAVLVEEGTDVSSFESFT
AEDAGGDKGAAPAQESKEESKGAADAAPASTPAPEPAAQEPETSGEKLQPSLDREPTISP
AAKALALEKGVPIKALKGTGRGGQITKEDVEKYKPSASAAAGPTYEDIPLTSMRKTIASR
LQQSTRENPHFFVSTTLSVTKLLKLRQALNASADGKYKLSVNDFLVKACAAALQKVPAVN
SSWHEENGQVVIRQHKNADISVAVATPAGLITPVVKNVQGLGLSSISNSIKDLGKRARDN
KLKPEEYQGGTFTISNMGMNPAVERFTAVINPPQAGILAVGTTRKVAVPVETENGTEVEW
DDQIIVTGSFDHKVVDGAVGAEWIKELKKVVENPLELLL


>AO090005000436 with intron
ATGGCTGACGTTGCTATCCCTATTTTCAGACCCCAATTGCCCGCCTTCGCTGCCCTTTCC
CGCTACTATGCCTCCAAGTGTACGCCCGTCCAGTTTTTATCCTTCTTATCTTCATAGTGC
AGTCGTCCAATTCTAACATGTCGAGTTGCAGCCTTCCCCCCTCACACTATCATTAGCATG
CCTGCTTTGTCGCCAACAATGCTTGCTGGAAACATCGGTGCCTGGCAGAAGAAGCCCGGC
GATTCCCTGCAGCCCGGAGATGTTTTGGTCGAGATTGAGACCGATAAGGCACAGATGGAT
TTCGAGTTCCAAGAAGAAGGTGTCTTGGCTAAAGTTCTGAAGGAAACTGGTGAGAAGGAG
GTTGCTGTCGGCTCCGTATGTGCTGCGATGCAAATTTTCAGTGTCCCGTATTGTTGCATT
TACTAATTGCGCGTCAACAGCCTATCGCCGTCCTCGTTGAAGAGGGCACTGATGTTTCGT
CGTTCGAGTCGTTCACCGCTGAGGATGCCGGTGGTGACAAGGGTGCTGCCCCAGCTCAGG
AGAGCAAGGAAGAATCCAAGGGTGCTGCTGATGCTGCTCCCGCTTCTACACCGGCTCCCG
AGCCTGCTGCTCAGGAGCCCGAGACCTCGGGTGAGAAGCTTCAGCCCAGTCTCGACCGTG
AGCCTACTATCAGCCCTGCTGCCAAGGCTCTTGCTCTGGAGAAGGGTGTGCCAATCAAGG
CCCTTAAGGGCACTGGCCGAGGCGGTCAGATCACCAAGGAGGATGTTGAGAAGTACAAGC
CCAGCGCTTCTGCCGCTGCTGGCCCTACCTATGAGGATATCCCTCTTACATCCATGCGCA
AGACTATTGCCAGCCGCCTTCAGCAATCCACCAGAGAGAACCCCCACTTCTTCGTCTCAA
CTACTCTGTCTGTCACTAAGCTTCTGAAGCTCCGCCAGGCCCTTAACGCCTCTGCCGATG
GCAAGTACAAGCTTTCCGTCAATGACTTCCTTGTCAAGGCTTGTGCTGCGGCTCTTCAGA
AGGTGCCGGCTGTCAACTCCAGCTGGCACGAGGAGAACGGCCAGGTAGTCATCCGCCAGC
ACAAGAATGCCGACATCAGTGTTGCCGTTGCCACTCCTGCTGGACTGATCACCCCTGTTG
TGAAGAACGTCCAGGGTCTCGGCCTCTCCAGCATCTCTAACTCTATCAAGGACCTTGGTA
AGCGTGCTCGCGACAACAAGCTTAAGCCGGAGGAGTACCAGGGTGGTACTTTCACCATCA
GCAACATGGGAATGAACCCTGCCGTTGAGCGGTTCACTGCTGTTATCAACCCCCCTCAGG
CTGGTATCCTGGCTGTTGGCACCACCCGCAAGGTTGCCGTCCCTGTTGAGACTGAGAACG
GTACCGAGGTTGAGTGGGACGACCAGATCATTGTGACTGGCAGCTTTGACCACAAGGTTG
TCGATGGTGCCGTTGGTGCTGAATGGATTAAGGAGCTGAAGAAGGTTGTTGAGAACCCCT
TGGAGCTGCTGCTCTAA

We have been distributing copies of the microbial genomic DNA clones constructed during the course of each of the genomic DNA sequencing projects.
You can find more detailed information at http://www.nbrc.nite.go.jp/e/mdna-e.html.